James Montgomery
Nurse Practitioner · Lenoir City, TNNPI 1568476182
Payments from drug & device makers
Across 278 payments — averaging $22.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$1K
- AstraZeneca$896
- CSL Behring$801
- Sanofi$564
- Regeneron Healthcare Solutions, Inc.$554
- Teva Pharmaceuticals USA, Inc.$405
- plus $2K from 19 others
What the payments were for
- Food & beverage$5,94396%
- Education$2454%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 67 | $1,056 |
| AstraZeneca | 36 | $896 |
| CSL Behring | 26 | $801 |
| Sanofi | 22 | $564 |
| Regeneron Healthcare Solutions, Inc. | 19 | $554 |
| Teva Pharmaceuticals USA, Inc. | 29 | $405 |
| Grifols USA, LLC | 12 | $355 |
| Genentech USA, Inc. | 14 | $290 |
| Sanofi-aventis U.S. LLC | 3 | $211 |
| Kaleo, Inc. | 11 | $209 |
| Novartis | 5 | $112 |
| Hospira, Inc. | 4 | $106 |
| Amgen | 4 | $97 |
| Pfizer | 4 | $85 |
| Biocryst US Sales Co., LLC | 4 | $75 |
| Optinose US, Inc. | 3 | $69 |
| Boehringer Ingelheim | 3 | $65 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $63 |
| Alk-abello, Inc | 2 | $41 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $40 |
| Ionis Pharmaceuticals, Inc. | 1 | $23 |
| Lilly USA, LLC | 1 | $21 |
| Hikma Pharmaceuticals USA | 1 | $19 |
| Blueprint Medicines Corporation | 1 | $17 |
| Pharming Healthcare, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,188 in reported general payments places this provider in the 90th percentile of 2,662 nurse practitioner providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| HizentraImmun Glob G(Igg)/Pro/Iga 0-50 | 13 | $79,992 |
| Breo ElliptaFluticasone/Vilanterol | 18 | $16,094 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 17 | $11,008 |
| Advair HfaFluticasone Propion/Salmeterol | 27 | $8,855 |
| SymbicortBudesonide/Formoterol Fumarate | 29 | $8,707 |
| Azelastine Hcl | 155 | $5,650 |
| Arnuity ElliptaFluticasone Furoate | 19 | $5,408 |
| Epinephrine | 21 | $4,413 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 21 | $3,169 |
| Fluticasone Propionate | 144 | $2,994 |
| Ipratropium Bromide | 53 | $1,675 |
| Wixela InhubFluticasone Propion/Salmeterol | 12 | $1,485 |
| Mometasone Furoate | 22 | $1,212 |
| Montelukast Sodium | 109 | $1,117 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 31 | $980 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| CSL BehringHizentra | $801 | $79,99213 claims |
| GSKBreo Ellipta, Trelegy Ellipta, Arnuity Ellipta | $1,056 | $32,50954 claims |
| AstraZenecaSymbicort | $896 | $8,70729 claims |
| Hikma Pharmaceuticals USAEpinephrine | $19 | $4,41321 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,662 nurse practitioner providers in Tennessee.
Other nurse practitioner in Lenoir City
- Amy HatcherMurfreesboro$1.1M
- Karen RodenKnoxville$265K
- Susan UtleyNashville$194K
- Whitney EricksonMemphis$159K
- Erica HembreeKnoxville$125K
- Brooke FaughtNashville$89K
- Lauren WelchNashville$71K
- Cara StoutKingsport$71K
- S Marie HamiltonOoltewah$64K
- Cynthia WilsonChattanooga$62K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.